Home
About
Overview
Sharing Data
ORCID
Help
History (55)
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
T lymphocyte response to Neisseria gonorrhoeae porin in individuals with mucosal gonococcal infections.
How one bad protein spoils the barrel: structural details of ?2-microglobulin amyloidogenicity.
Functional proteomics of the active cysteine protease content in Drosophila S2 cells.
Progress in prevention: adding a cerebral dimension.
See All 55 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Progress in prevention: adding a cerebral dimension.
Hughes S, Hayman LL. Progress in prevention: adding a cerebral dimension. J Cardiovasc Nurs. 2006 May-Jun; 21(3):242-3.
View in:
PubMed
subject areas
American Heart Association
Female
Health Education
Health Knowledge, Attitudes, Practice
Humans
Male
Self Care
Stroke
Thrombolytic Therapy
Tissue Plasminogen Activator
United States
authors with profiles
Laura L Hayman PhD